| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Modeling a lethal prostate cancer variant with small-cell carcinoma features. | Clin Cancer Res | 2011 | 1.15 |
| 2 | Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature. | Clin Cancer Res | 2011 | 0.98 |
| 3 | Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells. | PLoS One | 2013 | 0.77 |